The adenovirus-mediated transfer of PTEN inhibits the growth of esophageal cancer cells in vitro and in vivo

Bioscience, Biotechnology and Biochemistry

Volumn 74, Issue 4, 2010, Pages 736-740

  Zhou, Yong An ^a   Zhang, Tao ^a   Zhao, Jin Bo ^a   Wang, Xiao Ping ^a   Jiang, Tao ^a   Gu, Zhong Ping ^a   Wang, Xian Ni ^a   Li, Xiao Fei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Adenovirus; Gene therapy; Human esophageal cancer; PTEN

Indexed keywords

BIOLOGICAL MARKERS; CONTROL-CELL; DOWN-REGULATION; ESOPHAGEAL CANCER; IN-CELL; IN-VITRO; IN-VIVO; INDUCED APOPTOSIS; OVER-EXPRESSION; PTEN EXPRESSION; SUBCUTANEOUS TUMOR; THERAPEUTIC TARGETS; TUMOR SIZE; TUMOR SUPPRESSOR PHOSPHATASE;

CELL CULTURE; CELL DEATH; GENETIC ENGINEERING; TUMORS;

GENE THERAPY;

PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN PROTEIN, HUMAN;

ADENOVIRUS; ADENOVIRUS INFECTION; ANIMAL; APOPTOSIS; ARTICLE; CARCINOMA; DOWN REGULATION; ESOPHAGUS TUMOR; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; NUDE MOUSE; PHYSIOLOGY; RANDOMIZATION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ANIMALS; APOPTOSIS; CARCINOMA; CELL LINE, TUMOR; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; MICE, NUDE; NEOPLASMS; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RANDOM ALLOCATION;

ADENOVIRIDAE;

EID: 77951523000     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1271/bbb.90787     Document Type: Article

References (18)

1. Carnero A, Blanco-Aparicio C, Renner O, Link W, and Leal JF, Curr. Cancer Drug Targets, 8, 87-98 (2008).
2. Bahk YY, Cho IH, and Kim TS, Biochem. Biophys. Res. Commun., 377, 1199-1204 (2008).
3. Song MS, Salmena L, Carracedo A, Egia A, Lo-Coco F, Teruya-Feldstein J, and Pandolfi PP, Nature, 455, 813-817 (2008).
4. Kalaany NY and Sabatini DM, Nature, 458, 725-731 (2009).
5. Sos ML, Koker M, Weir BA, Heynck S, Kashkar H, Pao W, Meyerson M, and Thomas RK, Cancer Res., 69, 3256-3261 (2009).
6. Rosser CJ, Tanaka M, Pisters LL, Tanaka N, Levy LB, Hoover DC, Grossman HB, McDonnell TJ, Kuban DA, and Meyn RE, Cancer Gene Ther., 11, 273-279 (2004).
7. Tanaka M and Grossman HB, Gene Ther., 10, 1636-1642 (2003).
8. Chang D, Wang TY, Li HC, Wei JC, and Song JX, Dis. Esophagus, 20, 491-496 (2007).
9. Hildebrandt MA, Yang H, Hung MC, Izzo JG, Huang M, Lin J, Ajani JA, and Wu X, J. Clin. Oncol., 27, 857-871 (2009).
10. Blanco-Aparicio C, Renner O, Leal JF, and Carnero A, Carcinogenesis, 28, 1379-1386 (2007).
11. Teng Y, Sun AN, Pan XC, Yang G, Yang LL, Wang MR, and Yang X, Cancer Res., 66, 6972-6981 (2006).
12. Hahnfeldt P, Panigrahy D, Folkman J, and Hlatky L, Cancer Res., 59, 4770-4775 (1999).
13. Abounader R, Expert Rev. Anticancer Ther., 9, 235-245 (2009).
14. Herlevsen M, Oxford G, Ptak C, Shabanowitz J, Hunt DF, Conaway M, and Theodorescu D, Biochem. Biophys. Res. Commun., 352, 549-555 (2007).
15. Doki Y, Imoto M, Han EK, Sgambato A, and Weinstein IB, Carcinogenesis, 18, 1139-1148 (1997).
16. Xie JJ, Xu LY, Zhang HH, Cai WJ, Mai RQ, Xie YM, Yang ZM, Niu YD, Shen ZY, and Li EM, Biochem. Biophys. Res. Commun., 337, 355-362 (2005).
17. Li P, Zhang ST, Yu ZL, Wu YD, Liu X, Xu CM, and Cho CH, Dis. Esophagus, 22, 21-31 (2009).
18. Yang HL, Dong YB, Elliott MJ, Liu TJ, and McMasters KM, Clin. Cancer Res., 6, 1579-1589 (2000).